[Skip to Content]

Upstate Active Clinical Trials

Study Title:

Phase III Trial of Stereotactic Radiosurgery (SRS) versus Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) for Brain Metastases from Small Cell Lung Cancer

What is the purpose of the study? (in Layman's terms, please describe the study)

This study is being done to answer the following question:
Will high dose radiation therapy delivered only to the small areas of brain cancer and avoiding the surrounding normal brain tissue, called stereotactic radiosurgery (SRS), decrease side effects related to memory and thinking compared to radiation to the entire brain, called, whole-brain radiation therapy (WBRT) that avoids the hippocampus but treats all of the brain tissue along with a drug that helps preserve memory and thinking called memantine?

Upstate Institutional Review Board (IRB) Number:

1750922

Study/Protocol ID:

NRG-CC009

Study Phase:

III

Patient Age Group:

Adults

Principal Investigator:

Michael D Mix, MD

Who is eligible?

You may be eligible to take part in this study if you have small cell lung cancer, which has spread to your brain. Other inclusion criteria apply. Please contact the CRA for more information.

What is involved if I participate?

  • How long is the study?
    12 Months
  • Is transportation provided or reimbursed?
    No
  • Is parking provided or reimbursed?
    Yes
  • What tests and procedures are involved?
    Please contact the CRA for more information.

Where will the study take place?

SUNY Upstate Medical University
Upstate Cancer Center at the Hill - Radiation Oncology
Upstate Cancer Center at Oswego - Radiation Oncology
Upstate Cancer Center at Verona

Other Information:

Please contact the CRA for more information.

Who can I contact for more information?

Name: Erin Bingham, CCRP
Phone: 315-464-3603
Email: [email protected]

Return to Previous Page || Search Again

Top